Clover Health Investments announced that its flagship clinical decision support tool, Clover Assistant, is now generally available for external payors and providers under the brand name Counterpart Assistant. This strategic move with Counterpart Health, a subsidiary of Clover Health, aims to extend the benefits of data-driven proven technology, personalized care to a wider audience, enabling enhanced patient outcomes and reduced healthcare costs across the nation. Key Highlights: Strategic Expansion: CA will now support healthcare providers outside Clover Health’s Medicare Advantage plan, broadening its impact on patient care and operational efficiency, and giving Clover a new pathway to growth leveraging its existing technology assets. Robust Revenue Model: The new offering will employ a hybrid SaaS and shared-savings model, with options for full capitation. This ensures flexibility and alignment of financial incentives with improved health outcomes. Unmatched Features: CA’s differentiated technology-centric model delivers rapid value-based success via data, artificial intelligence, and machine learning to enhance the data and suggestions available to clinicians and improve patient care. Comprehensive Support: Leveraging Clover’s extensive experience with its own MA plan, Counterpart Health provides full implementation support, including training, integration assistance, and ongoing technical support. CA’s cloud-native architecture ensures scalability. Proven in Value-Based Care: Clinicians using Counterpart Assistant see over 1,000 basis point differential in Medical Cost Ratios. Proven Clinical Outcome Improvement: Clover has released retrospective data analyses exploring the significant association between CA use and early diagnosis of Diabetes and Chronic Kidney Disease as well as improved Medication Adherence.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV: